92 related articles for article (PubMed ID: 11275367)
21. The role of cyclosporin A on antibody-dependent monocyte-mediated cytotoxicity against human multidrug-resistant cancer cells.
Yano S; Yanagawa H; Hanibuchi M; Pai K; Nishioka Y; Tsuruo T; Sone S
J Med Invest; 1998 Feb; 44(3-4):185-91. PubMed ID: 9597807
[TBL] [Abstract][Full Text] [Related]
22. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
23. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.
Brezicka T; Bergman B; Olling S; Fredman P
Lung Cancer; 2000 Apr; 28(1):29-36. PubMed ID: 10704706
[TBL] [Abstract][Full Text] [Related]
24. Generation of two murine monoclonal antibodies that can discriminate N-glycolyl and N-acetyl neuraminic acid residues of GM2 gangliosides.
Miyake M; Ito M; Hitomi S; Ikeda S; Taki T; Kurata M; Hino A; Miyake N; Kannagi R
Cancer Res; 1988 Nov; 48(21):6154-60. PubMed ID: 3167861
[TBL] [Abstract][Full Text] [Related]
25. Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2.
Wu X; Okada N; Momota H; Irie RF; Okada H
J Immunol; 1999 Jan; 162(1):533-9. PubMed ID: 9886430
[TBL] [Abstract][Full Text] [Related]
26. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
[TBL] [Abstract][Full Text] [Related]
27. An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line.
Kiura K; Watarai S; Ueoka H; Tabata M; Gemba K; Aoe K; Yamane H; Yasuda T; Harada M
Anticancer Res; 1998; 18(4C):2957-60. PubMed ID: 9713491
[TBL] [Abstract][Full Text] [Related]
28. Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.
Nabioullin R; Yanagawa H; Haku T; Hiramatsu K; Yano S; Hanibuchi M; Pai K; Tsuruo T; Sone S
Jpn J Clin Oncol; 1995 Aug; 25(4):124-30. PubMed ID: 7666588
[TBL] [Abstract][Full Text] [Related]
29. Ganglioside GM2 expression on human melanoma cells correlates with sensitivity to lymphokine-activated killer cells.
Hoon DS; Ando I; Sviland G; Tsuchida T; Okun E; Morton DL; Irie RF
Int J Cancer; 1989 May; 43(5):857-62. PubMed ID: 2714890
[TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
Yamaguchi H; Furukawa K; Fortunato SR; Livingston PO; Lloyd KO; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1990 May; 87(9):3333-7. PubMed ID: 2159145
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
Ohta S; Igarashi S; Honda A; Sato S; Hanai N
Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645
[TBL] [Abstract][Full Text] [Related]
32. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
Kono K; Takahashi A; Ichihara F; Sugai H; Fujii H; Matsumoto Y
Cancer Res; 2002 Oct; 62(20):5813-7. PubMed ID: 12384543
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2.
Karlsson G; Månsson JE; Wikstrand C; Bigner D; Svennerholm L
Biochim Biophys Acta; 1990 Apr; 1043(3):267-72. PubMed ID: 1691018
[TBL] [Abstract][Full Text] [Related]
34. Biosynthesis and expression of the disialoganglioside GD2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis.
Cheresh DA; Rosenberg J; Mujoo K; Hirschowitz L; Reisfeld RA
Cancer Res; 1986 Oct; 46(10):5112-8. PubMed ID: 3019521
[TBL] [Abstract][Full Text] [Related]
35. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
[TBL] [Abstract][Full Text] [Related]
36. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
37. Tumor-cell killing by MAbs against fucosyl GM1, a ganglioside antigen associated with small-cell lung carcinoma.
Brezicka FT; Holmgren J; Kalies I; Lindholm L
Int J Cancer; 1991 Dec; 49(6):911-8. PubMed ID: 1660040
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc).
Sanai Y; Yamasaki M; Nagai Y
Biochim Biophys Acta; 1988 Feb; 958(3):368-74. PubMed ID: 2449247
[TBL] [Abstract][Full Text] [Related]
39. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Liu Z; Lee FT; Hanai N; Smyth FE; Burgess AW; Old LJ; Scott AM
Cancer Immun; 2002 Oct; 2():13. PubMed ID: 12747758
[TBL] [Abstract][Full Text] [Related]
40. Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients.
Segatori VI; Cuello HA; Gulino CA; Albertó M; Venier C; Guthmann MD; Demarco IA; Alonso DF; Gabri MR
Cancer Immunol Immunother; 2018 Aug; 67(8):1285-1296. PubMed ID: 29936534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
